The series of science and technology dreamers：
Academician Xiaodong Wang
【LWBS 2015 02 14 A】(SpringRain translated from People's Web) People's Web and the Ministry of Science Forum, People's TV, "Science and Technology Daily", "Chinese Science" and other media jointly launched the " Science and Technology Dreamers" series of interviews with figures of biological research section to show the respectable and lovely aspects of the scientists by excavating their work and life.
This gentleman has multiple identities: in addition to the director of National Institute of Biological Sciences, Beijing (NIBS), he was an academician of the American Academy of Sciences and Chinese Academy of Sciences. Xiaodong Wang is 50 years old and his inside is full of "adventure" spirit. He led a group of like-minded young people to practice the "inaction" of the science and technology system exploration. In past 12 years, they worked with students in the "experimental field" of NIBS,
In July 2004, the test run of NIBS began from a bold attempt: hiring a bunch of young returnees who just finished postdoctoral training to take PI positions in the laboratories to explore the frontiers. "These young people are around 30-year-old and have not led independently a laboratory in a foreign country, in the end how far they can go in the scientific road, to be honest, I'm not very sure." Talking about this "test", Director Wang Xiaodong frankly said. "However, 10 years late, they did better than I had expected."
Since 2006, these principle investigators who are averagely younger than 40-year-old have published more than 30 papers of high levels in just three top international scientific journals of "natural", "science" and "cell", and has created many important original results in the fields related to the national economy and the frontiers of life science. For example, Feng Shao's laboratory has systematically revealed the molecular mechanisms of bacterial pathogen invasion and defense of the innate immune system, for a number of important human pathogenic bacteria pathogenic mechanisms provides in-depth explanation, and for solving the ills of sepsis provides a new approach, he was awarded in 2013 the Young Scientist Award of the International Society of Protein, becoming China's first one as a local scientist for this award; The findings in Wenhui Li's laboratory about the receptor that mediates the hepatitis B virus infection with human cells, hopefully opened the door to cure hepatitis B, so he was invited by the WHO to join the expert evaluation of hepatitis B immune escape cooperation council ......
In addition to the NIBS, Xiaodong is also concerned by people because of "China's Genentech". BeiGene was academically founded by Xiaodong Wang, known as "China's Genentech", is promising based on the view of industry. BeiGene, a China life science biotechnology company, is headquartered in Beijing, and dedicated to the exploration and development of the effective new anticancer drugs for common cancers in China and Asia-Pacific area. BeiGene has more than a dozen of novel drugs of targeted or immune therapy at the different stages of development. Currently, there are three small-molecule drugs under ongoing clinical development, such as BTK inhibitor drug candidate BGB-3111 entered into the clinic phase I trial in August 2014, a PARP inhibitor BGB-290 entered into clinic phase I trial in July 2014, and the second-generation B-RAF inhibitor BGB-283 entered into clinic phase I trial in November 2013. By 2015, BeGene will have two or three new drug candidates into the clinic trials. (LiveWell-BioScience.com)
The video of Xiaodong Wang's interview by People's TV